Spondyloarthropathies
News
Foundation turns spotlight on psoriatic arthritis
News
Low infliximab start dose appears effective in psoriatic arthritis
Key clinical point: Most patients with psoriatic arthritis fare well on a lower than recommended starting dose.Major finding: Median starting...
Conference Coverage
Physically demanding jobs link to worse ankylosing spondylitis progression
Key clinical point: Patients with AS who have more physically demanding jobs showed greater radiographic progression than did patients with more...
Conference Coverage
Gut inflammation linked to worsening spondyloarthritis
Major finding: Among patients with newly diagnosed spondyloarthritis, microscopic gut inflammation at baseline was linked to a two-fold higher...
Conference Coverage
Treat to target shows durable improvements in psoriatic arthritis
News
Brodalumab outperformed placebo for psoriatic arthritis
Key clinical point: Interleukin-17 receptor A is a potential treatment target in psoriatic arthritis patients, whether or not they have received...
Conference Coverage
Apremilast appears to have multiple, lasting benefits in psoriatic arthritis
Key clinical point: Apremilast maintained its efficacy and safety profile through 1 year of treatment.Major finding: At 52 weeks, 55%-63% of...
News
Inflammation correlates with new bone formation in ankylosing spondylitis
Key clinical point: New bone formation in ankylosing spondylitis correlates with inflammation.Major finding: Patients with an ASDAS less than 1.3...
Conference Coverage
Step-down etanercept fails to control ankylosing spondylitis
Key clinical point: All the patients who did not maintain disease control after halving their dose of etanercept were able to regain clinical...